Showing results (671-680 of 1,033) with videos related to
Sort By:
Pageof 104
NPJ Parkinson'S Disease|July 4, 2026
Dopamine replacement therapy modulates DDC, prolactin and AOC3 levels in Parkinson's diseaseLudo van Hillegondsberg, Shahzad Ahmad, Tanja Zerenner, et al.Journal of the American Heart Association|January 19, 2017
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE TrialPeter T Hu, Renato D Lopes, Susanna R Stevens, et al.Cell|April 16, 2004
IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3aMickey C-T Hu, Dung-Fang Lee, Weiya Xia, et al.Brain : a Journal of Neurology|January 29, 2000
Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET studyM T Hu, S D Taylor-Robinson, K R Chaudhuri, et al.Annals of Clinical and Translational Neurology|August 13, 2019
Predicting motor, cognitive & functional impairment in Parkinson'sChristine Lo, Siddharth Arora, Fahd Baig, et al.Cell Cycle (Georgetown, Tex.)|December 3, 2011
Involvement of the nuclear proteasome activator PA28γ in the cellular response to DNA double-strand breaksAdva Levy-Barda, Yaniv Lerenthal, Anthony J Davis, et al.Zhonghua Xin Xue Guan Bing Za Zhi|August 26, 2020
[Analysis on the efficacy and safety of fibrinolytic therapy in patients with acute ST-segment elevation myocardial infarction during the COVID-19 epidemic]F Wei, X X Shuai, Z J Chen, et al.Molecular Neurodegeneration|June 26, 2016
Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementiaChristopher J Holler, Georgia Taylor, Zachary T McEachin, et al.Journal of Materials Science. Materials in Medicine|September 2, 2008
XPS and biocompatibility studies of titania film on anodized NiTi shape memory alloyC L Chu, R M Wang, T Hu, et al.Parkinsonism & Related Disorders|June 16, 2018
A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's diseaseMonty A Silverdale, Christopher Kobylecki, Lewis Kass-Iliyya, et al.Pageof 104